Testing the "garbage" accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy.
Imperfect autophagic degradation of oxidatively damaged macromolecules and organelles (so-called biological "garbage") is considered an important contributor to ageing and consequent death of postmitotic (non-dividing) cells, such as neurons and cardiac myocytes. In contrast, proliferating cells apparently escape senescence by a continuous dilution and repair of damaged structures during division. Postmitotic ageing can be mimicked and studied in cultures of potentially dividing cells if their mitotic activity is inhibited. To test the "garbage accumulation" theory of ageing, we compared survival of density-dependent growth-arrested (confluent) and proliferating human fibroblasts and astrocytes following inhibition of autophagic sequestration with 3-methyladenine (3MA). Exposure of confluent fibroblast cultures to 3MA for two weeks resulted in a significantly increased proportion of dying cells compared to both untreated confluent cultures and dividing cells with 3MA-inhibited autophagy. Similar results were obtained when autophagic degradation was suppressed by the protease inhibitor leupeptin. In 3MA- or leupeptin-exposed cultures, dying cells were overloaded with undegraded autofluorescent material. The results support a key role of biological lysosomal "garbage" accumulation in the triggering of ageing and death of postmitotic cells, as well as the anti-ageing role of cell division.
Stroikin
Yuri
Y
Division of Experimental Pathology II Faculty of Health Sciences, Linköping University, Sweden. yurst@inr.liu.se
Dalen
Helge
H
Brunk
Ulf T
UT
Terman
Alexei
A
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000375:Aging / Q000378:metabolism / Q000502:physiology*; D001253:Astrocytes; D001343:Autophagy; D002460:Cell Line; D002470:Cell Survival; D016922:Cellular Senescence; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D005347:Fibroblasts; D006801:Humans; D007976:Leupeptins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008938:Mitosis; D000081082:Phosphoinositide-3 Kinase Inhibitors
D015853:Cysteine Proteinase Inhibitors; D007976:Leupeptins; D000081082:Phosphoinositide-3 Kinase Inhibitors; C025946:3-methyladenine; C032854:leupeptin; D000225:Adenine